This brand name is authorized in Malta, United Kingdom
The drug ZOMORPH contains one active pharmaceutical ingredient (API):
|
1
Morphine
UNII X3P646A2J0 - MORPHINE SULFATE
|
|
Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AA01 | Morphine | N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 36517, 36522, 37781, 38818, 40357 |
| Country: MT | Medicines Authority | Identifier(s): AA565/50401 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
